The standard of secondary prevention of stroke in Czech patients in the EUROASPIRE III Study - Stroke Specific Module;Úroveň sekundární prevence cévních mozkových příhod u českých pacientů ve studii EUROASPIRE III - Stroke Specific Module

Cor et Vasa

Volumn 50, Issue 12, 2008, Pages 446-454

  Bruthans, Jan ^a   Mayer Jr , Otto ^b   Šimon, Jaroslav ^b   Galovcová, Markéta ^a   Hrbková, Jana ^b   Bělohoubek, Jiři ^a   Patraulea, Monica ^b   Jeschke, Jiří ^b   Rosolová, Hana ^b   Cífková, Renata ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

EUROASPIRE III Study; Ischemic stroke; Secondary prevention; Stroke Specific Module

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; WARFARIN;

AGED; ANXIETY; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CZECH REPUBLIC; DEPRESSION; DIABETES CONTROL; DIABETES MELLITUS; DIET; DIET RESTRICTION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; OUTPATIENT CARE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; SMOKING; STRUCTURED QUESTIONNAIRE;

EID: 58149204272     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2008.167     Document Type: Article

References (23)

1. Kalita Z a kol. Akutní cévní mozkové příbody. Diagnostika, patofyziologie, management. Praha: Maxdorf, 2006:623.
2. Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-4.
3. Sacco RL, Adams R, Albers G, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke of Transient Ischemic Attack. A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37:577-617.
4. European Stroke Initiative: European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies. Cerebrovasc Dis 2000; 10:335-51.
5. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee: Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008;25:457-507.
6. Kalita Z, Keller O, Bar M, et al. Doporučený postup sekundární prevence u ischemických cévních mozkových příhod. Česká neurologická společnost 2008. www.czech-neuro.cz/
7. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehab 2007; 14 (Suppl 2): S1-S113.
8. Cífková R. Prevence ischemické choroby srdeční v dospélém věku. Společné doporučení českých odborných společností. Cor Vasa 2000;42:K225-K234.
9. Kalita Z. Doporučení pro diagnostiku a léčbu cévních mozkových pčíhod. Česká kardiologická společnost 2008. www.kardio-cz.cz/index
10. Mayer O, Šimon J, Galovcová M, a spol. Úroveň sekundární prevence ischemické choroby srdeční u českých pacientů ve studii EUROASPIRE III. Cor Vasa 2008;50:156-62.
11. Hagströmer M, Oja P, Sjöström M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 2006; 9:755-62.
12. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
13. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J 1965; 14:61-5.
14. Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 2007;29:417-24.
15. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741-8.
16. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regiment among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
17. Cífková R, Škodová Z, Lánská V, et al. Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross sectional surveys in 1997/98 and 2000/ 01, Czech Post-MONICA Study. J Hum Hypertens 2004; 18:571-9.
18. Amarenco P, Bogousslovsky J, Callahan A, et al. High dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
19. Duckworth WC. Glycemic Control and Cardiovascular Outcomes - The VA Diabetes Trial. Oral communication presented at the 68th annual meeting of the American Diabetes Association. June 6-10, 2008, San Francisco, CA.
20. The Action to Control Cardiovascular Risk in Diabetes Study Group. N Engl J Med 2008;358:2545-59.
21. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomiscd trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
22. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
23. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1287-9.